Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S K Libutti

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Annals of Surgical Oncology|October 11, 2002
Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcomaT E Lans, T L M ten Hagen, R van Horssen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancerA L Feldman, L Tamarkin, G F Paciotti, et al.
Annals of Surgical Oncology|January 5, 2002
A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levelsS K Libutti, H R Alexander, P Choyke, et al.
Microvascular Research|June 30, 2000
Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesisA C Berger, H R Alexander, G Tang, et al.
Surgery|December 15, 2000
Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau diseaseS K Libutti, P L Choyke, H R Alexander, et al.
Cancer Gene Therapy|November 17, 2012
Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activityZ Yuan, G Syrkin, A Adem, et al.
Surgery|December 22, 1999
Results of heterotopic parathyroid autotransplantation: a 13-year experienceA L Feldman, R N Sharaf, M C Skarulis, et al.
Journal of Clinical Pharmacology|April 10, 1999
Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosisH K Cho, R M Lush, D L Bartlett, et al.
Biotechniques|September 20, 2002
Microarray gene expression profiling of angiogenesis inhibitors using the rat aortic ring assayT G Zogakis, N G Costouros, E A Kruger, et al.
Surgery|December 15, 2000
Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomasD L Feingold, H R Alexander, C C Chen, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Annals of Surgical Oncology|October 11, 2002
Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte-activating polypeptide II in soft tissue sarcomaT E Lans, T L M ten Hagen, R van Horssen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Serum endostatin levels are elevated and correlate with serum vascular endothelial growth factor levels in patients with stage IV clear cell renal cancerA L Feldman, L Tamarkin, G F Paciotti, et al.
Annals of Surgical Oncology|January 5, 2002
A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levelsS K Libutti, H R Alexander, P Choyke, et al.
Microvascular Research|June 30, 2000
Endothelial monocyte activating polypeptide II induces endothelial cell apoptosis and may inhibit tumor angiogenesisA C Berger, H R Alexander, G Tang, et al.
Surgery|December 15, 2000
Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau diseaseS K Libutti, P L Choyke, H R Alexander, et al.
Cancer Gene Therapy|November 17, 2012
Blockade of inhibitors of apoptosis (IAPs) in combination with tumor-targeted delivery of tumor necrosis factor-α leads to synergistic antitumor activityZ Yuan, G Syrkin, A Adem, et al.
Surgery|December 22, 1999
Results of heterotopic parathyroid autotransplantation: a 13-year experienceA L Feldman, R N Sharaf, M C Skarulis, et al.
Journal of Clinical Pharmacology|April 10, 1999
Pharmacokinetics of cisplatin administered by continuous hyperthermic peritoneal perfusion (CHPP) to patients with peritoneal carcinomatosisH K Cho, R M Lush, D L Bartlett, et al.
Biotechniques|September 20, 2002
Microarray gene expression profiling of angiogenesis inhibitors using the rat aortic ring assayT G Zogakis, N G Costouros, E A Kruger, et al.
Surgery|December 15, 2000
Ultrasound and sestamibi scan as the only preoperative imaging tests in reoperation for parathyroid adenomasD L Feingold, H R Alexander, C C Chen, et al.
Pageof 10